Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy

Nanomedicine

Volumn 8, Issue 1, 2013, Pages 17-28

  Black, Kvar C L ^a,b   Yi, Ji ^a   Rivera, José G ^a   Zelasko Leon, Daria C ^a   Messersmith, Phillip B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibody; biomimetic adhesion; EGF receptor; mussel foot proteins; nanoparticle; optical imaging; photothermal therapy; plasmon; surface modification

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GOLD NANOPARTICLE; NANOROD; POLYDOPAMINE; POLYMER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BIOMIMETICS; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG CONJUGATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ILLUMINATION; PARTICLE SIZE; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; PROTEIN TARGETING; SURFACE PLASMON RESONANCE;

EID: 84871576852     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.82     Document Type: Article

References (85)

1. Gatenby R, Vincent T. An evolutionary model of carcinogenesis. Cancer Res. 63, 6212-6220 (2003
2. Gatenby R, Gillies R. A microenvironmental model of carcinogenesis. Nat Rev Cancer 8(1), 56-61 (2008
3. Agra IMG, Carvalho AL, Pinto CA et al. Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch. Otolaryngol Head Neck Surg. 134(7), 743-749 (2008
4. Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9-22 (2011
5. Vanden Bempt I, Drijkoningen M, Wolf- Peeters CD. The complexity of genotypic alterations underlying HER2-positive breast cancer: An explanation for its clinical heterogeneity. Curr. Opin. Oncol. 19, 552-557 (2007
6. Schaefer NG, Pestalozzi BC, Knuth A, Renner C. Potential use of humanized antibodies in the treatment of breast cancer. Expert Rev. Anticancer Ther. 6(7), 1065-1074 (2006
7. Li S, Schmitz K, Jeffrey PD, Wiltzius JJW, Kussie P, Ferguson KM. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7, 301-311 (2005
8. Subramanian A, Mokbel K. The role of herceptin in early breast cancer. Int. Semin. Surg. Oncol. 5, 9 (2008
9. Hynes NE, Lane HA. ERBB receptors and cancer: The complexity of targeted inhibitors. Nature Rev. Cancer 5, 341-354 (2005
10. Gatenby R, Vincent T. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol. Cancer Ther. 2(9), 919-927 (2003
11. Jabr-Milane L, Vlerken LV, Yadav S, Amiji M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev. 34(7), 592-602 (2008
12. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007
13. El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics. Applications in oral cancer. Nano Lett. 5(5), 829-834 (2005
14. Hadjipanayis CG, Machaidze R, Kaluzova M et al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging - guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 70(15), 6303-6312 (2010
15. Liu D, Chen C, Hu G et al. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging. Acta Biochim. Biophys. Sin. (Shanghai) 43, 301-306 (2011
16. Thomas TP, Shukla R, Kotlyar A et al. Dendrimer-epidermal growth factor conjugate displays superagonist activity. Biomacromolecules 9, 603-609 (2008
17. Zhang Z, Chen J, Ding L et al. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting. Small 6(3), 430-437 (2010
18. Tsutsui Y, Tomizawa K, Nagita M et al. Development of bionanocapsules targeting brain tumors. J. Control. Release 122, 159-164 (2007
19. Milane L, Duan Z, Amiji M. Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/ lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. Mol. Pharm. 8(1), 185-203 (2011
20. Liu P, Li Z, Zhu M et al. Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma. J. Mater. Sci. Mater. Med. 21, 551-556 (2010
21. Magadala P, Amiji M. Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells. AAPS J. 10(4), 565-576 (2008
22. Löw K, Dipl-Biola, Wacker M, Wagner S, Langer K, Briesen HV. Targeted human serum albumin nanoparticles for specific uptake in EGFR-expressing colon carcinoma cells. Nanomedicine 7, 454-463 (2011
23. Peng XH, Wang Y, Huang D et al. Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS Nano 5(12), 9480-9493 (2011
24. Kim SK, Huang L. Nanoparticle delivery of a peptide targeting EGFR signaling. J. Control. Release 157(2), 279-286 (2011
25. Loo C, Lin A, Hirsch L et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol. Cancer Res. Treat. 3(1), 33-40 (2004
26. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond.) 2(5), 681-693 (2007
27. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng JX, Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond.) 2(1), 125-132 (2007
28. Willets KA, Van Duyne RP. Localized surface plasmon resonance spectroscopy and sensing. Annu. Rev. Phys. Chem. 58, 267-297 (2007
29. Black KCL, Kirkpatrick ND, Troutman TS et al. Gold nanorods targeted to delta opioid receptor: Plasmon-resonant contrast and photothermal agents. Mol. Imaging 7(1), 50-57 (2008
30. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38(6), 1759-1782 (2009
31. Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA. Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed. Engl. 49(19), 3280-3294 (2010
32. Alkilany AM, Thompson LB, Boulos SP, Sisco PN, Murphy CJ. Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv. Drug Deliv. Rev. 64(2), 190-199 (2011
33. Stone J, Jackson S, Wright D. Biological applications of gold nanorods. WIREs Nanomed. Nanobiotechnol. 3, 100-109 (2011
34. Murphy CJ, Thompson LB, Alkilany AM et al. The many faces of gold nanorods. J. Phys. Chem. Lett. 1(19), 2867-2875 (2010
35. Huang XH, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128(6), 2115-2120 (2006
36. Huang X, Peng X, Wang Y et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4(10), 5887-5896 (2010
37. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: Molecular origin of cytotoxicity and surface effects. Small 5(6), 701-708 (2009
38. Alkilany AM, Nagaria PK, Wyatt MD, Murphy CJ. Cation exchange on the surface of gold nanorods with a polymerizable surfactant: Polymerization, stability, and toxicity evaluation. Langmuir 26(12), 9328-9333 (2010
39. Boca SC, Astilean S. Detoxification of gold nanorods by conjugation with thiolated poly(ethylene glycol) and their assessment as SERS-active carriers of Raman tags. Nanotechnology 21, 235601 (2010
40. Grabinski C, Schaeublin N, Wijaya A et al. Effect of gold nanorod surface chemistry on cellular response. ACS Nano 5(4), 2870-2879 (2011
41. Waite JH. Nature's underwater adhesive specialist. Int. J. Adhes. Adhes. 7, 9-14 (1987
42. Lee BP, Messersmith PB, Israelachvili JN, Waite JH. Mussel-inspired adhesives and coatings. Annu. Rev. Mater. Res. 41, 99-132 (2011
43. Dalsin JL, Hu BH, Lee BP, Messersmith PB. Mussel adhesive protein mimetic polymers for the preparation of nonfouling surfaces. J. Am. Chem. Soc. 125, 4253-4258 (2003
44. Statz AR, Park JP, Chongsiriwatana NP, Barron AE, Messersmith PB. Surface-immobilized antimicrobial peptoids. Biofouling 24(6), 439-448 (2008
45. Xu C, Xu K, Gu H et al. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J. Am. Chem. Soc. 126, 9938-9939 (2004
46. Amstad E, Gillich T, Bilecka I, Textor M, Reimhult E. Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups. Nano Lett. 9(12), 4042-4048 (2009
47. He T, Shi ZL, Fang N, Neoh KG, Kang ET, Chan V. The effect of adhesive ligands on bacterial and fibroblast adhesions to surfaces. Biomaterials 30, 317-326 (2009
48. Gao C, Li G, Xue H, Yang W, Zhang F, Jiang S. Functionalizable and ultra-low fouling zwitterionic surfaces via adhesive mussel mimetic linkages. Biomaterials 31(7), 1486-1492 (2010
49. Hu X, Neoh KG, Shi Z, Kang ET, Poh C, Wang W. An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion. Biomaterials 31, 8854-8863 (2010
50. Gillich T, Benetti EM, Rakhmatullina E et al. Self-assembly of focal point oligo-catechol ethylene glycol dendrons on titanium oxide surfaces: Adsorption kinetics, surface characterization, and nonfouling properties. J. Am. Chem. Soc. 133, 10940-10950 (2011
51. Black K, Liu Z, Messersmith P. Catechol redox induced formation of metal core-polymer shell nanoparticles. Chem. Mater. 23(5), 1130-1135 (2011
52. Sun IC, Eun DK, Na JH et al. Heparin-coated gold nanoparticles for liver-specific CT imaging. Chem. Eur. J. 15, 13341-13347 (2009
53. Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coating. Science 318, 426-430 (2007
54. Poh CK, Shi Z, Lim TY, Neoh KG, Wang W. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials 31, 1578-1585 (2010
55. Kang S, Elimelech M. Bioinspired single bacterial cell force spectroscopy. Langmuir 25(17), 9656-9659 (2009
56. Ku SH, Ryu J, Hong SK, Lee H, Park CB. General functionalization route for cell adhesion on non-wetting surfaces. Biomaterials 31, 2535-2541 (2010
57. Ham HO, Liu Z, Lau KHA, Lee H, Messersmith PB. Facile DNA immobilization on surfaces through a catecholamine polymer. Angew. Chem. Int. Ed. 50, 732-736 (2011
58. Sileika TS, Kim HD, Maniak P, Messersmith PB. Antibacterial performance of polydopamine-modified polymer surfaces containing passive and active components. ACS Appl. Mater. Interfaces 3(12), 4602-4610 (2011
59. You I, Kang SM, Byun Y, Lee H. Enhancement of blood compatibility of poly(urethane) substrates by mussel-inspired adhesive heparin coating. Bioconjugate Chem. 22, 1264-1269 (2011
60. Hong S, Kim KY, Wook HJ et al. Attenuation of the in vivo toxicity of biomaterials by polydopamine surface modification. Nanomedicine 6(5), 793-801 (2011
61. Rim NG, Kim SJ, Shin YM et al. Mussel-inspired surface modification of poly(l-lactide) electrospun fibers for modulation of osteogenic differentiation of human mesenchymal stem cells. Colloids Surf. B Biointerfaces 1(91), 189-197 (2012
62. Kang K, Choi IS, Nam Y. A biofunctionalization scheme for neural interfaces using polydopamine polymer. Biomaterials 32, 6374-6380 (2011
63. Huang YF, Huang KM, Chang HT. Synthesis and characterization of Au core-Au-Ag shell nanoparticles from gold seeds: Impacts of glycine and pH. J. Colloid Interface Sci. 301, 145-154 (2006
64. Kalish LH, Kwong RA, Cole IE, Gallagher RM, Sutherland RL, Musgrove EA. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 10, 7764-7774 (2004
65. Fitzpatrick SL, Lachance MP, Schultz GS. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res. 44, 3442-3447 (1984
66. Huang HC, Barua S, Sharma G, Dey SK, Rege K. Inorganic nanoparticles for cancer imaging and therapy. J. Control. Release 155(3), 344-357 (2011
67. Choi WL, Sahu A, Kim YH, Tae G. Photothermal cancer therapy and imaging based on gold nanorods. Ann. Biomed. Eng. 40(2), 534-546 (2012
68. d'Ischia M, Napolitano A, Pezzella A, Meredith P, Sarna T. Chemical and structural diversity in eumelanins: Unexplored bio-optoelectronic materials. Angew. Chem. Int. Ed. Engl. 48, 3914-3921 (2009
69. Bernsmann F, Ponche A, Ringwald C et al. Characterization of dopamine-melanin growth on silicon oxide. J. Phys. Chem. C 113, 8234-8242 (2009
70. Bernsmann F, Ball V, Addiego F et al. Dopamine-melanin film deposition depends on the used oxidant and buffer solution. Langmuir 27, 2819-2825 (2011
71. Jiang J, Zhu L, Zhu L, Zhu B, Xu Y. Surface characteristics of a self-polymerized dopamine coating deposited on hydrophobic polymer films. Langmuir 27, 14180-14187 (2011
72. Bernsmann F, Voegel JC, Ball V. Different synthesis methods allow to tune the permeability and permselectivity of dopamine-melanin films to electrochemical probes. Electrochimica Acta 56, 3914-3919 (2011
73. Chen H, Kou X, Yang Z, Ni W, Wang J. Shape- and size-dependent refractive index sensitivity of gold nanoparticles. Langmuir 24, 5233-5237 (2008
74. Weinhold M, Soubatch S, Temirov R et al. Structure and bonding of the multifunctional amino acid l-DOPA on Au(110). J. Phys. Chem. B 110, 23756-23769 (2006
75. Ooka AA, R.L. Garrell. Surface-enhanced raman spectroscopy of DOPA-containing peptides related to adhesive protein of marine mussel, mytilus edulis. Biopolymers 57, 92-102 (2000
76. Capala J, Bouchelouche K. Molecular imaging of HER2-positive breast cancer: A step toward an individualized 'image and treat' strategy. Curr. Opin. Oncol. 22, 559-566 (2010
77. Evans A, Bates V, Troy H et al. Glut-1 as a therapeutic target: Increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother. Pharmacol. 61, 377-393 (2008
78. Wang L, Chen H, Pourgholami MH et al. Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model. PLoS ONE 6(9), E24405 (2011
79. Bernsmann F, Frisch B, Ringwald C, Ball V. Protein adsorption on dopamine-melanin films: Role of electrostatic interactions inferred from zeta-potential measurements versus chemisorption. J. Colloid Interface Sci. 344, 54-60 (2010
80. Haeder M, Rotsch M, Bepler G et al. Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res. 48, 1132-1136 (2010
81. Handl HL, Sankaranarayanan R, Josan JS et al. Synthesis and evaluation of bivalent NDP-r-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R). Bioconjugate Chem. 18, 1101-1109 (2007
82. Jang B, Kim YS, Choi Y. Effects of gold nanorod concentration on the depth-related temperature increase during hyperthermic ablation. Small 7(2), 265-270 (2011
83. Tong L, Zhao Y, Huff TB, Hansen MN, Wei A, Cheng JX. Gold nanorods mediate tumor cell death by compromising membrane integrity. Adv. Mat. 19, 3136-3141 (2007
84. Kogan MJ, Olmedo I, Hosta L, Guerrero AR, Cruz LJ, Albericio F. Peptides and metallic nanoparticles for biomedical applications. Nanomedicine (Lond.) 2(3), 287-306 (2007
85. Lee JH, Yigit MV, Mazumdar D, Lua Y. Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. Adv. Drug Deliv. Rev. 62, 592-605 (2010